{
    "organizations": [],
    "uuid": "0ff810174cdaf381ddeefe737655e9404fcea60c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-opiant-pharmaceuticals-reports-q1/brief-opiant-pharmaceuticals-reports-q1-loss-per-share-3-68-idUSASC0A0N2",
    "ord_in_thread": 0,
    "title": "BRIEF-Opiant Pharmaceuticals Reports Q1 Loss Per Share $3.68",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Opiant Pharmaceuticals Inc:\n* OPIANT PHARMACEUTICALS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* Q1 LOSS PER SHARE $3.68 * QTRLY TOTAL REVENUE $1.7 MILLION VERSUS $11,000 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T06:51:00.000+03:00",
    "crawled": "2018-05-09T12:27:28.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "opiant",
        "pharmaceutical",
        "inc",
        "opiant",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "qtrly",
        "total",
        "revenue",
        "million",
        "versus",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}